Amoebas from the genus Acanthamoeba and their pathogenic properties

• Autorzy: Kot K. , Lanocha-Arendarczyk N.A. , Kosik-Bogacka D.I.
• Języki publikacji: EN

Abstrakty

EN

Amoebas from the genus Acanthamoeba are cosmopolitan organisms, which can exist as free-living organisms and as parasites within host tissue. Acanthamoeba infection present a serious risk to human health and are characterized by high mortality, especially in immunocompromised individuals. These protozoa are the etiological factors of granulomatous amoebic encephalitis (GAE) and Acanthamoeba keratitis (AK). They can also live in the lungs, adrenals glands, nose, throat, and bones of the host. Furthermore, the amoebas can be vectors of pathogenic bacteria. Acanthamoeba infection caused is a serious clinical problem mainly due to limited progress in diagnostics and treatment of this infection, which is associated with insufficient knowledge of pathogenesis, pathophysiology and the host immune response against Acanthamoeba antigens. This review study presents the biology of Acanthamoeba sp. as well as pathogenicity, diagnostics, and treatment of amoebas infections. It also presents data, including experimental results, concerning pathogenic properties and the host’s immunology response against Acanthamoeba sp.

• Wydawca: -
• Czasopismo: Annals of Parasitology
• Rocznik: 2018
• Tom: 64
• Numer: 4
• Opis fizyczny: p.299-308,ref.

Twórcy

autor

Kot K.

• Department of Biology and Medical Parasitology, Faculty of Medicine, Biotechnology and Laboratory Medicine, Pomeranian Medical University in Szczecin, Powstancow Wielkopolskich 72, 70-111 Szczecin, Poland

autor

Lanocha-Arendarczyk N.A.

• Department of Biology and Medical Parasitology, Faculty of Medicine, Biotechnology and Laboratory Medicine, Pomeranian Medical University in Szczecin, Powstancow Wielkopolskich 72, 70-111 Szczecin, Poland

autor

Kosik-Bogacka D.I.

• Department of Biology and Medical Parasitology, Faculty of Medicine, Biotechnology and Laboratory Medicine, Pomeranian Medical University in Szczecin, Powstancow Wielkopolskich 72, 70-111 Szczecin, Poland

Bibliografia

• [1] Cano A., Mattana A., Woods S., Henriquez F.L., Alexander J., Roberts C.W. 2017. Acanthamoeba activates macrophages predominantly through tolllike receptor 4- and MyD88-dependent mechanisms to induce interleukin-12 (IL-12) and IL-6. Infection and Immunity 85: e01054-16. doi:10.1128/iai.01054-16
• [2] Anacarso I., de Niederhäusern S., Messi P., Guerrieri E., Iseppi R., Sabia C., Bondi M. 2012. Acanthamoeba polyphaga, a potential environmental vector for the transmission of food-borne and opportunistic pathogens. Journal of Basic Microbiology 52: 261- 268. doi:10.1002/jobm.201100097
• [3] Clarke D.W., Niederkorn J.Y. 2006. The immunobiology of Acanthamoeba keratitis. Microbes and Infection 8: 1400-1405. doi:10.1016/j.micinf.2005.12.009
• [4] Mortazavi P.N., Goldsworthy G., Kirk R., Khan N.A. 2010. Acanthamoeba produces disseminated infection in locusts and traverses the locust bloodbrain barrier to invade the central nervous system. BMC Microbiology 10: 186. doi:10.1186/1471-2180-10-186
• [5] Gianinazzi C., Schild M., Zumkehr B., Wüthrich F., Nüesch I., Ryter R., Schürch N., Gottstein B., Müller N. 2010. Screening of Swiss hot spring resorts for potentially pathogenic free-living amoebae. Experimental Parasitology 126: 45-53. doi:10.1016/j.exppara.2009.12.008
• [6] Feng X., Zheng W., Wang Y., Zhao D., Jiang X., Lv S. 2015. A rabbit model of Acanthamoeba keratitis that better reflects the natural human infection. Anatomical Record 298: 1509-1517. doi:10.1002/ar.23154
• [7] Ren M., Wu X. 2010. Evaluation of three different methods to establish animal models of Acanthamoeba keratitis. Yonsei Medical Journal 51: 121-127. doi:10.3349/ymj.2010.51.1.121
• [8] Łanocha N., Kosik-Bogacka D., Maciejewska A., Sawczuk M., Wilk A., Kuźna-Grygiel W. 2009. The occurence Acanthamoeba (free living amoeba) in environmental and respiratory samples in Poland. Acta Protozoologica 48: 271-279.
• [9] Khan N.A. 2006. Acanthamoeba: biology and increasing importance in human health. FEMS Microbiology Reviews 30: 564-595. doi:10.1111/j.1574-6976.2006.00023.x
• [10] Khan N.A., Tareen N.K. 2003. Genotypic, phenotypic, biochemical, physiological and pathogenicity-based categorisation of Acanthamoeba strains. Folia Parasitologica 50: 97-104. doi:10.14411/fp.2003.017
• [11] Mazur T., Hadaś E., Iwanicka I. 1995. The duration of the cyst stage and the viability and virulence of Acanthamoeba isolates. Tropical Medicine and Parasitology 46: 106-108.
• [12] Siddiqui R., Khan N.A. 2012. Biology and pathogenesis of Acanthamoeba. Parasites and Vectors 5: 6. doi:10.1186/1756-3305-5-6
• [13] Kasprzak W. 1985. Pełzaki wolnożyjące o właściwościach patogenicznych dla człowieka i zwierząt. Państwowe Wydawnictwo Naukowe, Warszawa (in Polish).
• [14] Kłopocka W., Rędowicz M.J., Wasik A. 2009. Regulacja dynamiki cytoszkieletu kortykalnego podczas migracji swobodnie żyjących ameb [Regulation of cortical cytoskeleton dynamics during migration of free-living amoebae]. Postępy Biochemii 55: 129-137 (in Polish with summary in English).
• [15] Derda M., Wojtkowiak-Giera A., Kolasa-Wołosiuk A., Kosik-Bogacka D., Hadaś E., Jagodziński P.P., Wandurska-Nowak E. 2016. Acanthamoeba infection in lungs of mice expressed by toll-like receptors (TLR2 and TLR4). Experimental Parasitology 165: 30-34. doi:10.1016/j.exppara.2016.02.012
• [16] Taher E.E., Méabed E.M.H., Abdallah I., Abdel Wahed W.Y. 2018. Acanthamoeba keratitis in noncompliant soft contact lenses users: genotyping and risk factors, a study from Cairo, Egypt. Journal of Infection and Public Health 11: 377-383. doi:10.1016/j.jiph.2017.09.013
• [17] Behera H.S., Satpathy G., Tripathi M. 2016 Isolation and genotyping of Acanthamoeba spp. from Acanthamoeba meningitis/meningoencephalitis (AME) patients in India. Parasites and Vectors 9: 442. doi:10.1186/s13071-016-1729-5
• [18] Corsaro D., Walochnik J., Köhsler M., Rott M.B. 2015. Acanthamoeba misidentification and multiple labels: redefining genotypes T16, T19, and T20 and proposal for Acanthamoeba micheli sp. nov. (genotype T19). Parasitology Research 114: 2481-2490. doi:10.1007/s00436-015-4445-8
• [19] Fuerst P.A., Booton G.C., Crary M. 2015. Phylogenetic analysis and the evolution of the 18S rRNA gene typing system of Acanthamoeba. Journal of Eukaryotic Microbiology 62: 69-84. doi:10.1111/jeu.12186
• [20] The Ohio State University. 2017. Genomes of Acanthamoeba.https://u.osu.edu/acanthamoeba/genomes- of-acanthamoeba
• [21] Brindley N., Matin A., Khan N.A. 2009. Acanthamoeba castellanii: high antibody prevalence in racially and ethnically diverse populations. Experimental Parasitology 121: 254-256. doi:10.1016/j.exppara.2008.11.009
• [22] Lorenzo-Morales J., Martín-Navarro C.M., López-Arencibia A., Arnalich-Montiel F., Piñero J.E., Valladares B. 2013. Acanthamoeba keratitis: an emerging disease gathering importance worldwide? Trends in Parasitology 29: 181-187. doi:10.1016/j.pt.2013.01.006
• [23] Khezri A., Fallah E., Mostafazadeh M., Spotin A., Shahbazi A., Mahami-Oskouei M., Hazratian T. 2016. Molecular and morphometric characterization of Acanthamoeba spp. from different water sources of northwest Iran as a neglected focus, co-bordeed with the country of Iraq. Jundishapur Journal of Microbiology 9: e38481. doi:10.5812/jjm.38481
• [24] Tawfeek G.M., Bishara S.A.-H., Sarhan R.M., Taher E.E., Khayyal A.E. 2016. Genotyping, physiological and biochemical characterization of potentially pathogenic Acanthamoeba isolated from the environment in Cairo, Egypt. Parasitology Research 115: 1871-1881. doi:10.1007/s00436-016-4927-3
• [25] Król-Turmińska K., Olender A. 2017. Human infections caused by free-living amoebae. Annals of Agricultural and Environmental Medicine 24: 254-260. doi:10.5604/12321966.1233568
• [26] Cholewiński M., Hadaś E., Derda M., Wojt J.W., Skrzypczak Ł. 2013. Występowanie patogenicznych pełzaków wolno żyjących z rodzaju Acanthamoeba w piaskownicach miejskich [The occurrence of the pathogenic free-living amoeba from Acanthamoeba genus in city’s sandboxes]. Nowiny Lekarskie 82: 138-141 (in Polish with summary in English).
• [27] Trabelsi H., Dendana F., Sellami A., Sellami H., Cheikhrouhou F., Neji S., Makni F., Ayadi A. 2012. Pathogenic free-living amoebae: epidemiology and clinical review. Pathologie Biologie 60: 399-405. doi:10.1016/j.patbio.2012.03.002
• [28] Berger P., Papazian L., Drancourt M., La Scola B., Auffray J.P., Raoult D. 2006. Ameba-associated microorganisms and diagnosis of nosocomial pneumonia. Emerging Infectious Diseases 12: 248-255. doi:10.3201/eid1202.050434
• [29] Visvesvara G.S., Moura H., Schuster F.L. 2007. Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri and Sappinia diploidea. FEMS Immunology and Medical Microbiology 50: 1-26. doi:10.1111/j.1574-695X.2007.00232.x
• [30] Memari F., Niyyati M., Joneidi Z. 2017. Pathogenic Acanthamoeba T4 genotype isolated from mucosal tissue of a patient with HIV infection: a case report. Iranian Journal of Parasitology 12: 143-147.
• [31] Michalek M., Sönnichsen F.D., Wechselberger R., Dingley A.J., Hung C.-W., Kopp A., Wienk H., Simanski M., Herbst R., Lorenzen I., Marciano-Cabral F., Gelhaus C., Gutsmann T., Tholey A., Grötzinger J., Leippe M. 2013. Structure and function of a unique pore-forming protein from a pathogenic Acanthamoeba. Nature Chemical Biology 9: 37-42.
• [32] Lorenzo-Morales J., Khan N.A., Walochnik J. 2015. An uptade on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment. Parasite 22: 10. doi:10.1051/parasite/2015010
• [33] Hadaś E. 1993. Badania biochemiczne wykładników inwazyjności i wirulencji pełzaków z rodzaju Acanthamoeba [Study on biochemical exponents of Acanthamoeba invasiveness and virulence]. Akademia Medyczna, Poznań, Poland (in Polish).
• [34] Podlipaeva Yu.I., Shmakova L.A., Gilichinski D.A., Goodkov A.V. 2006. [Heat shock protein of HSP70 family revealed in some contemporary freshwater amoebae and in Acanthamoeba sp. excysted from cysts isolated from permafrost samples]. Tsitologiya 48: 691-694 (in Russian with summary in English).
• [35] Panjwani N. 2010. Pathogenesis of Acanthamoeba keratitis. Ocular Surface 8: 70-79. doi:10.1016/s1542-0124(12)70071-x
• [36] Thomas V., McDonell G., Denyer S.P., Maillard J.-Y. 2010. Free-living amoebae and their intracellular pathogenic microorganisms: risks for water quality. FEMS Microbiology Reviews 34: 231-259. doi:10.1111/j.1574-6976.2009.00190.x
• [37] Ren M.Y., Wu X.Y. 2011. Toll-like receptor 4 signalling pathway activation in a rat model of Acanthamoeba Keratitis. Parasite Immunol 33: 25-33. doi:10.1111/j.1365-3024.2010.01247.x
• [38] Pachówka M., Kluk M., Korczak-Kowalska G. 2009. Rola receptorów Toll-podobnych (TLR) w indukcji i regulacji [Role of Toll-like receptors (TLR) in induction and regulation of immune response]. Postępy Biologii Komórki 36: 429-442 (in Polish with summary in English).
• [39] Wojtkowiak-Giera A., Derda M., Kolasa-Wołosiuk A., Hadaś E., Kosik-Bogacka D., Solarczyk P., Jagodziński P.P., Wandurska-Nowak E. 2016. Tolllike receptors in the brain of mice following infection with Acanthamoeba spp. Parasitology Research 115: 4335-4344. doi:10.1007/s00436-016-5217-9
• [40] Alizadeh H., Tripathi T., Abdi M., Smith A.D. 2014. Pathogenic strains of Acanthamoeba are recognized by TLR4 and initiated inflammatory responses in the cornea. PLoS One 9: e92375. doi:10.1371/journal.pone.0092375
• [41] Neelam S., Niederkorn J.Y. 2017. Pathobiology and Immunobiology of Acanthamoeba keratitis: insights from animal models. Yale Journal of Biology and Medicine 90: 261-268.
• [42] Ferrante A., Rowan-Kelly B. 1983. Activation of the alternative pathway of complement by Acanthamoeba culbertsoni. Clinical and Experimental Immunology 54: 477-485.
• [43] van Klink F., Alizadeh H., He Y., Mellon J.A., Silvany R.E., McCulley J.P., Niederkorn J.Y. 1993. The role of contact lenses, trauma, and Langerhans cells in a Chinese hamster model of Acanthamoeba keratitis. Investigative Ophthalmology and Visual Science 34: 1937-1944.
• [44] Benedetto N., Rossano F., Gorga F., Folgore A., Rao M., Romano Carratelli C. 2003. Defense mechanisms of IFN-γ and LPS-primed murine microglia against Acanthamoeba castellanii infection. International Immunopharmacology 3: 825-834. doi:10.1016/s1567-5769(03)00047-x
• [45] Stewart G.L., Shupe K., Kim I., Silvany R.E., Alizadeh H., McCulley J.P., Niederkorn J.Y. 1994. Antibody-dependent neutrophil-mediated killing of Acanthamoeba castellanii. International Journal for Parasitology 24: 739-742. doi:10.1016/0020-7519(94)90129-5
• [46] Mattana A., Sanna M., Cano A., Delogu G., Erre G., Roberts C.W., Henriquez F.L., Fiori P.L., Cappuccinelli P. 2016. Acanthamoeba castellanii genotype T4 stimulates the production of interleukin-10 as well as proinflammatory cytokines in THP-1 cells, human peripheral blood mononuclear cells, and human monocyte-derived macrophages. Infection and Immunity 84: 2953-2962. doi:10.1128/iai.00345-16
• [47] Toney D.M., Marciano-Cabral F. 1998. Resistance of Acanthamoeba species to complement lysis. Journal of Parasitology 84: 338-344. doi:10.2307/3284492
• [48] Harrison J.L., Ferreira G.A., Raborn E.S., Lafrenaye A.D., Marciano-Cabral F., Cabral G.A. 2010. Acanthamoeba culbertsoni elicits soluble factors that exert anti-microglial cell activity. Infection and Immunity 78: 4001-4011.doi:10.1128/iai.00047-10
• [49] Knickelbein J.E., Kovarik J., Dhaliwal D.K., Chu C.T. 2013. Acanthamoeba keratitis: a clinicopathologic case report and review of the literature. Human Pathology 44: 918-922. doi10.1016/j.humpath.2012.10.007
• [50] Kim J.-Y., Na B.-K., Song K.-J., Park M.-H., Park Y.-K., Kim T.-S. 2012. Functional expression and characterization of an iron-containing superoxide dismutase of Acanthamoeba castellanii. Parasitology Research 111: 1673-1682. doi:10.1007/s00436-012-3006-7
• [51] Suryawanshi A., Cao Z., Sampson J.F., Panjwani N. 2015. IL-17A-mediated protection against Acanthamoeba keratitis. Journal of Immunology 194: 650-663. doi:10.4049/jimmunol.1302707
• [52] Ricciotti E., FitzGerald G.A. 2011. Prostaglandins and inflammation. Arteriosclerosis, Thrombosis and Vascular Biology 31: 986-1000. doi:10.1161/atvbaha.110.207449
• [53] Łanocha-Arendarczyk N., Baranowska-Bosiacka I., Kot K., Gutowska I., Kolasa-Wołosiuk A., Chlubek D., Kosik-Bogacka D. 2018. Expression and activity of COX-1 and COX-2 in Acanthamoeba sp.-infected lungs according to the host immunological status. International Journal of Molecular Sciences 19: 121. doi:10.3390/ijms19010121
• [54] Diaz J.H. 2010. Increasing intracerebral infections caused by free-living amebae in the United States and Worldwide. Journal of Neuroparasitology 1: 104. doi:10.4303/jnp/n100801
• [55] Łanocha-Arendarczyk N., Kosik-Bogacka D., Galant K., Zaorski W., Kot K., Łanocha A. 2017. Pełzaki wolno żyjące o właściwościach patogenicznych dla człowieka [Pathogenic free-living amoeba]. Postępy Mikrobiologii 56: 106-112 (in Polish with summary in English).
• [56] Salameh A., Bello N., Becker J., Zangeneh T. 2015. Fatal granulomatous amoebic encephalitis caused by Acanthamoeba in a patient with kidney transplant: a case report. Open Forum Infectious Diseases 2: ofv104. doi:10.1093/ofid/ofv104
• [57] Khan N.A., Siddiqui R. 2011. The neuropathogenesis of Acanthamoeba encephalitis: barriers to overcome. Journal of Cell Science and Therapy S3: 001. doi:10.4172/2157-7013.s3-001
• [58] Visvesvara G.S., Stehr-Green J.K. 1990. Epidemiology of free-living ameba infections. Journal of Protozoology 37: 25s-33s. doi:10.1111/j.1550-7408.1990.tb01142.x
• [59] Martínez A.J., Visvesvara G.S. 2001. Balamuthia mandrillaris infection. Journal of Medical Microbiology 50: 205-207. doi:10.1099/0022-1317-50-3-205
• [60] Marciano-Cabral F., Cabral G. 2003. Acanthamoeba spp. as agents of disease in humans. Clinical Microbiology Reviews 16: 273-307. doi:10.1128/cmr.16.2.273-307.2003
• [61] Karsenti N., Lau R., Purssell A., Chong-Kit A., Cunanan M., Gasgas J., Tian J., Wang A., Ralevski F., Boggild A.K. 2017. Development and validation of a real-time PCR assay for the detection of clinical acanthamoebae. BMC Research Notes 10: 355. doi:10.1186/s13104-017-2666-x
• [62] Gupta R., Gorski M., Henderson T., Lazzaro D., Haseeb M.A. 2015. Clinical course of unilateral Acanthamoeba keratitis in a cosmetic contact lens wearer. Annals of Clinical and Laboratory Science 45: 366-370.
• [63] Culbertson C.G., Smith J.W., Minner J.R. 1958. Acanthamoeba: observations on animal pathogenicity. Science 127: 1506. doi:10.1126/science.127.3313.1506
• [64] Górnik K., Kuźna-Grygiel W. 2005. Histological studies of selected organs of mice experimentally infected with Acanthamoeba spp. Folia Morphologica 64: 161-167.
• [65] Mahgoub A.M.A. 2010. Acanthamoeba keratitis. Parasitologists United Journal 3: 9-18.
• [66] Naginton J., Watson P.G., Playfair T.J., McGill J., Jones B.R., Steele A.D. 1974. Amoebic infection of the eye. Lancet 2: 1537-1540. doi:10.1016/S0140-6736(74)90285-2
• [67] Hadaś E., Derda M. 2013. Pełzakowe zapalenie rogówki oka - nowe zagrożenie epidemiologiczne [Acanthamoeba keratitis – the new epidemiological threat]. Problemy Higieny i Epidemiologii 94: 730-733 (in Polish with summary in English).
• [68] Wesołowska M., Cisowska A., Myjak P., Marek J., Jurowskaka-Liput J., Jakubaszko J. 2006. Acanthamoeba keratitis in contact lens wearers in Poland. Advances in Clinical and Experimental Medicine 15: 553-555.
• [69] Visvesvara G.S. 2010. Free-living amebae as opportunistic agents of human disease. Journal of Neuroparasitology 1. doi:10.4303/jnp/N100802
• [70] Omaña-Molina M., Hernandez-Martinez D., Sanchez-Rocha R., Cardenas-Lemus U., Salinas-Lara C., Mendez-Cruz A.R., Colin-Barenque Lv, Aley-Medina P., Espinosa-Villanueva J., Moreno-Fierros L., Lorenzo-Morales J. 2017. In vivo CNS infection model of Acanthamoeba genotype T4: the early stages of infection lack presence of host inflammatory response and are a slow and contactdependent process. Parasitology Research 116: 725-733. doi:10.1007/s00436-016-5338-1
• [71] Kong H.-H., Kim T.-H., Chung D.-I. 2000. Purification and characterization of a secretory serine proteinase of Acanthamoeba healyi isolated from GAE. Journal of Parasitology 86: 12-17. doi:10.2307/3284901
• [78] Sissons J., Kim K.S., Stins M., Jayasekera S., Alsam S., Khan N.A. 2005. Acanthamoeba castellanii induces host cell death via a phosphatidylinositol 3-kinase-dependent mechanism. Infection and Immunity 73: 2704-2708. doi:10.1128/iai.73.5.2704-2708.2005
• [79] Clarke B., Sinha A., Parmar D.N., Sykakis E. 2012. Advances in the diagnosis and treatment of Acanthamoeba keratitis. Journal of Ophthalmology 2012: 484892. doi:10.1155/2012/484892
• [80] Wilhelmus K.R., Jones D.B., Matoba A.Y., Hamill M.B., Pfugfelder S.C., Weikert M.P. 2008. Bilateral Acanthamoeba keratitis. American Journal of Ophthalmology 145: 193-197. doi:10.1016/j.ajo.2007.09.037
• [81] Sengor T., Kurna S.A., Altun A., Irkec M., Aki S.F., Aksoy S. 2015. Contact lens-related Acanthamoeba keratitis and accompanying dacryoadenitis. Eye Contact Lens 41: 204-209. doi:10.1097/icl.0000000000000114
• [82] Dart J.K.G., Saw V.P.J., Kilvington S. 2009. Acanthamoeba keratitis: diagnosis and treatment update 2009. American Journal of Ophthalmology 148: 487-499. doi:10.1016/j.ajo.2009.06.009
• [83] Prasher P., Sachdeva P., Ravinder N.B., Sachin W. 2004. Acanthamoeba keratitis: a review. North Zone Ophthalmological Society 14: 1-7.
• [84] Visvesvara G.S. 2013. Infections with free-living amebae. Handbook of Clinical Neurology 114: 153-168. doi:10.1016/b978-0-444-53490-3.00010-8
• [85] Walochnik J., Scheikl U., Haller-Schober E.-M. 2015. Twenty years of Acanthamoeba diagnostics in Austria. Journal of Eukaryotic Microbiology 62: 3-11. doi:10.1111/jeu.12149
• [86] Kaiserman I., Bahar I., McAllum P., Srinivasan S., Elbaz U., Slomovic A.R., Rootman D.S. 2012. Prognostic factors in Acanthamoeba keratitis. Canadian Journal of Ophthalmology 47: 312-317. doi:10.1016/j.jcjo.2012.03.040
• [87] Seal D.V. 2003. Acanthamoeba keratitis update-incidence, molecular epidemiology and new drugs for treatment. Eye 17: 893-905. doi:10.1038/sj.eye.6700563
• [88] Tomita S., Suzuki C., Wada H., Nomachi M., Imayasu M., Araki-Sasaki K. 2017. Effects of lactoferrin on the viability and the encystment of Acanthamoeba trophozoites. Biochemistry and Cell Biology 95: 48-52. doi:10.1139/bcb-2016-0054
• [89] Hadaś E., Derda M., Cholewiński M. 2017. Evaluation of the effectiveness of tea tree oil in treatment of Acanthamoeba infection. Parasitology Research 116: 997-1001. doi:10.1007/s00436-017-5377-2
• [90] Zhou Q., Liu X.-Y., Ruan Y.-X., Wang L., Jiang M.-M., Wu J., Chen J. 2015. Construction of corneal epithelium with human amniotic epithelial cells and repair of limbal deficiency in rabbit models. Human Cell 28: 22-36. doi:10.1007/s13577-014-0099-6
• [91] Young A.L., LeBoeuf N.R., Tsiouris S.J., Husain S., Grossman M.E. 2010. Fatal disseminated Acanthamoeba infection in a liver transplant recipient immunocompromised by combination therapies for graft-versus-host disease. Transplant Infectious Disease 12: 529-537. doi:10.1111/j.1399-3062.2010.00535.x
• [92] Sison J.P., Kemper C.A., Loveless M., McShane D., Visvesvara G.S., Deresinski S.C. 1995. Disseminated Acanthamoeba infection in patients with AIDS: case reports and review. Clinical Infectious Diseases 20: 1207-1216. doi:10.1093/clinids/20.5.1207
• [93] Torno Jr. M.S., Babapour R., Gurevitch A., Witt M.D. 2000. Cutaneous acanthamoebiasis in AIDS. Journal of the American Academy of Dermatology 42: 351-354. doi:10.1016/s0190-9622(00)90110-5
• [94] Walia R., Montoya J.G., Visvesvera G.S., Booton G.C., Doyle R.L. 2007. A case of successful treatment of cutaneous Acanthamoeba infection in a lung transplant recipient. Transplant Infectious Disease 9: 51-54. doi:10.1111/j.1399-3062.2006.00159.x
• [95] Galarza C., Ramos W., Gutierrez E.L., Ronceros G., Teran M., Uribe M., Navincopa M., Ortega-Loayza A.G. 2009. Cutaneous acanthamebiasis infection in immunocompetent and immunocompromised patients. International Journal of Dermatology 48: 1324-1329. doi:10.1111/j.1365-4632.2008.03786.x
• [96] Im K.I., Kim D.S. 1998. Acanthamoebiasis in Korea: two new cases with clinical cases review. Yonsei Medical Journal 39: 478-484. doi:10.3349/ymj.1998.39.5.478
• [97] Kaul D.R., Lowe L., Visvesvara G.S., Farmen S., Khaled Y.A., Yanik G.A. 2008. Acanthamoeba infection in a patient with chronic graft-versus-host disease occurring during treatment with voriconazole. Transplant Infectious Disease 10: 437-441. doi:10.1111/j.1399-3062.2008.00335.x
• [98] Steinberg J.P., Galindo R.L., Kraus E.S., Ghanem K.G. 2002. Disseminated acanthamebiasis in a renal transplant recipient with osteomyelitis and cutaneous lesions: case report and literature review. Clinical Infectious Diseases 35: e43-e49. doi:10.1086/341973

Identyfikatory

DOI

10.17420/ap6404.164